RecruitingNot ApplicableNCT07256119
Evaluation of the Effect of Alpha Lipoic Acid on Radiation Induced Dermatitis in Breast Cancer Patients
Sponsor
Ain Shams University
Enrollment
40 participants
Start Date
Aug 6, 2024
Study Type
INTERVENTIONAL
Conditions
Summary
the purpose of this study is to evaluate the Effect of Alpha Lipoic Acid on Radiation Induced Dermatitis in Breast Cancer Patients
Eligibility
Sex: FEMALEMin Age: 18 YearsMax Age: 75 Years
Inclusion Criteria3
- Women aged ≥18 years.
- Histologically confirmed invasive, early-stage breast carcinoma scheduled for adjuvant radiotherapy.
- Receiving total radiation dose of 40 Gy for 15 sessions.
Exclusion Criteria7
- Prior exposure to radiotherapy.
- Inflammatory or metastatic breast carcinoma.
- Patients with connective tissue disorders.
- Patients with skin inflammatory diseases (e.g. ectopic dermatitis).
- Patients with known allergy or hypersensitivity to alpha lipoic acid.
- Concomitant use of nonsteroidal anti-inflammatory drugs, corticosteroids, or antioxidant medications.
- Patients who will fail to sign the written consent.
Interventions
DIETARY_SUPPLEMENTAlpha Lipoic Acid
alpha lipoic acid 300 mg three times daily under the trade name of THIOTACID manufactured by EVAPHARMA.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07256119